With the release of Trial by Frost and the new Suspended and Banned list, big things are happening in Altered.

Novartis' strong drug pipeline and financials support an 11% annual return by 2027. Learn why NVS stock offers 33% return ...

Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary endpoint of preservation of lean mass as well as greater ...

(THE CONVERSATION) As research into psychedelics and their medical uses makes a comeback, scientists are having to deal with the legacy – both scientific and social – of a 40-year nearly total freeze ...

The Independent Data Monitoring Committee met this week on February 10, 2025 to evaluate the unblinded safety Phase 2b QUALITY data and recommended to continue the QUALITY extension study as designed- ...

French carrier Amelia is expanding a trial of contrail-avoidance technology from partners Thales and Breakthrough Energy ...

Acupuncture is proving effective for chronic sciatica relief A new clinical trial reveals its potential to reduce pain and ...

As of December 31, 2024, the Company had cash and cash equivalents in the amount of $15.6 million, compared to $5.3 million ...

Mereo BioPharma shifts focus to rare diseases with setrusumab showing strong results for Osteogenesis Imperfecta. Learn more on MREO stock here.

Part one of Anthony Sabino’s two-part series analyzing Texas Top Cop Shop, Inc. v. Garland holding the Corporate Transparency ...

Having a good work-life balance is good for your overall wellbeing. That’s why many countries have shorter working hours per ...

Campaigning began in the Philippines Tuesday for mid-term elections that could set the table for the next presidential race ...